Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

In the last several years, global market of Radiopharmaceuticals developed year by year, with an average growth rate of 8.02% for the sales. In 2016, global revenue of Radiopharmaceuticals is nearly 4546 M USD; the sale is about 130 M Dose.

The classification of Radiopharmaceuticals includes Diagnostic Radioisotopes, Therapeutic Radioisotopes. The proportion of Diagnostic Radioisotopes in 2016 is about 89.22%, and the proportion is in decreasing trend from 2012 to 2017. The Therapeutic Radioisotopes is enjoying more and more market share.

Radiopharmaceuticals are widely used in Oncology, Cardiology and Other disease diagnosis and treatment. The most of radiopharmaceuticals is used in Oncology, and the sales proportion in 2016 is about 62.63%.

According to this study, over the next five years the Radiopharmaceuticals market will register a 7.8% CAGR in terms of revenue, the global market size will reach US$ 7130 million by 2024, from US$ 4900 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Radiopharmaceuticals business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Radiopharmaceuticals market by product type, application, key manufacturers and key regions and countries.

This study considers the Radiopharmaceuticals value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.

Diagnostic Radioisotopes

Therapeutic Radioisotopes

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.

Oncology

Cardiology

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Bracco Imaging

Bayer

Mallinckrodt

Nordion

Triad Isotopes

Lantheus

IBA Group

GE Healthcare

China Isotope & Radiation

Jubilant Pharma

Eli Lilly

Advanced Accelerator Applications

SIEMENS

Dongcheng

Navidea

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Radiopharmaceuticals consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.

To understand the structure of Radiopharmaceuticals market by identifying its various subsegments.

Focuses on the key global Radiopharmaceuticals manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Radiopharmaceuticals with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Radiopharmaceuticals submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

2019-2024 Global Radiopharmaceuticals Consumption Market Report

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Economic Indicators

1.6 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Radiopharmaceuticals Consumption 2014-2024

2.1.2 Radiopharmaceuticals Consumption CAGR by Region

2.2 Radiopharmaceuticals Segment by Type

2.2.1 Diagnostic Radioisotopes

2.2.2 Therapeutic Radioisotopes

2.3 Radiopharmaceuticals Consumption by Type

2.3.1 Global Radiopharmaceuticals Consumption Market Share by Type (2014-2019)

2.3.2 Global Radiopharmaceuticals Revenue and Market Share by Type (2014-2019)

2.3.3 Global Radiopharmaceuticals Sale Price by Type (2014-2019)

2.4 Radiopharmaceuticals Segment by Application

2.4.1 Oncology

2.4.2 Cardiology

2.4.3 Other

2.5 Radiopharmaceuticals Consumption by Application

2.5.1 Global Radiopharmaceuticals Consumption Market Share by Application (2014-2019)

2.5.2 Global Radiopharmaceuticals Value and Market Share by Application (2014-2019)

2.5.3 Global Radiopharmaceuticals Sale Price by Application (2014-2019)

3 Global Radiopharmaceuticals by Players

3.1 Global Radiopharmaceuticals Sales Market Share by Players

3.1.1 Global Radiopharmaceuticals Sales by Players (2017-2019)

3.1.2 Global Radiopharmaceuticals Sales Market Share by Players (2017-2019)

3.2 Global Radiopharmaceuticals Revenue Market Share by Players

3.2.1 Global Radiopharmaceuticals Revenue by Players (2017-2019)

3.2.2 Global Radiopharmaceuticals Revenue Market Share by Players (2017-2019)

3.3 Global Radiopharmaceuticals Sale Price by Players

3.4 Global Radiopharmaceuticals Manufacturing Base Distribution, Sales Area, Product Types by Players

3.4.1 Global Radiopharmaceuticals Manufacturing Base Distribution and Sales Area by Players

3.4.2 Players Radiopharmaceuticals Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Radiopharmaceuticals by Regions

4.1 Radiopharmaceuticals by Regions

4.1.1 Global Radiopharmaceuticals Consumption by Regions

4.1.2 Global Radiopharmaceuticals Value by Regions

4.2 Americas Radiopharmaceuticals Consumption Growth

4.3 APAC Radiopharmaceuticals Consumption Growth

4.4 Europe Radiopharmaceuticals Consumption Growth

4.5 Middle East & Africa Radiopharmaceuticals Consumption Growth

5 Americas

5.1 Americas Radiopharmaceuticals Consumption by Countries

5.1.1 Americas Radiopharmaceuticals Consumption by Countries (2014-2019)

5.1.2 Americas Radiopharmaceuticals Value by Countries (2014-2019)

5.2 Americas Radiopharmaceuticals Consumption by Type

5.3 Americas Radiopharmaceuticals Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Radiopharmaceuticals Consumption by Countries

6.1.1 APAC Radiopharmaceuticals Consumption by Countries (2014-2019)

6.1.2 APAC Radiopharmaceuticals Value by Countries (2014-2019)

6.2 APAC Radiopharmaceuticals Consumption by Type

6.3 APAC Radiopharmaceuticals Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Radiopharmaceuticals by Countries

7.1.1 Europe Radiopharmaceuticals Consumption by Countries (2014-2019)

7.1.2 Europe Radiopharmaceuticals Value by Countries (2014-2019)

7.2 Europe Radiopharmaceuticals Consumption by Type

7.3 Europe Radiopharmaceuticals Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Spain

7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Radiopharmaceuticals by Countries

8.1.1 Middle East & Africa Radiopharmaceuticals Consumption by Countries (2014-2019)

8.1.2 Middle East & Africa Radiopharmaceuticals Value by Countries (2014-2019)

8.2 Middle East & Africa Radiopharmaceuticals Consumption by Type

8.3 Middle East & Africa Radiopharmaceuticals Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Radiopharmaceuticals Distributors

10.3 Radiopharmaceuticals Customer

11 Global Radiopharmaceuticals Market Forecast

11.1 Global Radiopharmaceuticals Consumption Forecast (2019-2024)

11.2 Global Radiopharmaceuticals Forecast by Regions

11.2.1 Global Radiopharmaceuticals Forecast by Regions (2019-2024)

11.2.2 Global Radiopharmaceuticals Value Forecast by Regions (2019-2024)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.5.6 Spain Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Radiopharmaceuticals Forecast by Type

11.8 Global Radiopharmaceuticals Forecast by Application

12 Key Players Analysis

12.1 Bracco Imaging

12.1.1 Company Details

12.1.2 Radiopharmaceuticals Product Offered

12.1.3 Bracco Imaging Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)

12.1.4 Main Business Overview

12.1.5 Bracco Imaging News

12.2 Bayer

12.2.1 Company Details

12.2.2 Radiopharmaceuticals Product Offered

12.2.3 Bayer Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)

12.2.4 Main Business Overview

12.2.5 Bayer News

12.3 Mallinckrodt

12.3.1 Company Details

12.3.2 Radiopharmaceuticals Product Offered

12.3.3 Mallinckrodt Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)

12.3.4 Main Business Overview

12.3.5 Mallinckrodt News

12.4 Nordion

12.4.1 Company Details

12.4.2 Radiopharmaceuticals Product Offered

12.4.3 Nordion Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)

12.4.4 Main Business Overview

12.4.5 Nordion News

12.5 Triad Isotopes

12.5.1 Company Details

12.5.2 Radiopharmaceuticals Product Offered

12.5.3 Triad Isotopes Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)

12.5.4 Main Business Overview

12.5.5 Triad Isotopes News

12.6 Lantheus

12.6.1 Company Details

12.6.2 Radiopharmaceuticals Product Offered

12.6.3 Lantheus Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)

12.6.4 Main Business Overview

12.6.5 Lantheus News

12.7 IBA Group

12.7.1 Company Details

12.7.2 Radiopharmaceuticals Product Offered

12.7.3 IBA Group Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)

12.7.4 Main Business Overview

12.7.5 IBA Group News

12.8 GE Healthcare

12.8.1 Company Details

12.8.2 Radiopharmaceuticals Product Offered

12.8.3 GE Healthcare Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)

12.8.4 Main Business Overview

12.8.5 GE Healthcare News

12.9 China Isotope & Radiation

12.9.1 Company Details

12.9.2 Radiopharmaceuticals Product Offered

12.9.3 China Isotope & Radiation Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)

12.9.4 Main Business Overview

12.9.5 China Isotope & Radiation News

12.10 Jubilant Pharma

12.10.1 Company Details

12.10.2 Radiopharmaceuticals Product Offered

12.10.3 Jubilant Pharma Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)

12.10.4 Main Business Overview

12.10.5 Jubilant Pharma News

12.11 Eli Lilly

12.12 Advanced Accelerator Applications

12.13 SIEMENS

12.14 Dongcheng

12.15 Navidea

13 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Radiopharmaceuticals

Table Product Specifications of Radiopharmaceuticals

Figure Radiopharmaceuticals Report Years Considered